Rennova Health (RNVA) Stock Statistics & Valuation Metrics

Rennova Health has a market cap or net worth of $43.05K. The enterprise value is $16.03M.

Rennova Health has 43,051,320,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rennova Health’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is -7.24%.

The current PE Ratio of Rennova Health is ―. Rennova Health’s PEG ratio is 0.00427.

In the last 12 months, Rennova Health had revenue of 18.69M and earned -7.73M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 3.39M and capital expenditures -350.93K, giving a free cash flow of 3.04M billion.

Rennova Health pays an annual dividend of ―, resulting in a dividend yield of ―

Rennova Health upcoming earnings date is ―, ―.

Rennova Health as a current ratio of 0.16, with Debt / Equity ratio of -31.98%

In the past 12 months, Rennova Health has paid 239.83K in taxes.

Rennova Health EV to EBITDA ratio is 10.36, with an EV/FCF ratio of 4.94.

Rennova Health has $49.02K in cash and marketable securities with $11.78M in debt, giving a net cash position of -$11.73M billion.

Gross margin is 59.46%, with operating margin of 7.31%, and net profit margin of -41.36%.

The average price target for Rennova Health is ―, which is 11.43% higher than the current price. The consensus rating is ―